PRATI, GIAN MARIA
 Distribuzione geografica
Continente #
EU - Europa 2.546
NA - Nord America 1.957
AS - Asia 1.849
Continente sconosciuto - Info sul continente non disponibili 302
SA - Sud America 163
AF - Africa 61
OC - Oceania 19
Totale 6.897
Nazione #
US - Stati Uniti d'America 1.857
GB - Regno Unito 954
CN - Cina 579
SG - Singapore 479
DE - Germania 431
IT - Italia 353
RU - Federazione Russa 177
SE - Svezia 155
BD - Bangladesh 150
VN - Vietnam 146
HK - Hong Kong 138
BR - Brasile 106
NL - Olanda 101
IN - India 99
FR - Francia 96
UA - Ucraina 91
CA - Canada 76
TR - Turchia 73
IE - Irlanda 62
KR - Corea 57
EU - Europa 44
FI - Finlandia 42
CI - Costa d'Avorio 23
CO - Colombia 23
ID - Indonesia 23
JP - Giappone 20
AU - Australia 16
DK - Danimarca 16
CL - Cile 14
BE - Belgio 13
AR - Argentina 10
PL - Polonia 10
PH - Filippine 9
PK - Pakistan 9
UG - Uganda 9
UZ - Uzbekistan 9
EG - Egitto 8
IR - Iran 8
TW - Taiwan 8
ZA - Sudafrica 8
CH - Svizzera 7
ES - Italia 7
IL - Israele 7
IQ - Iraq 7
MX - Messico 7
MY - Malesia 6
BG - Bulgaria 5
CR - Costa Rica 5
EC - Ecuador 5
SA - Arabia Saudita 5
AT - Austria 4
TH - Thailandia 4
EE - Estonia 3
GT - Guatemala 3
JO - Giordania 3
KE - Kenya 3
RO - Romania 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
IS - Islanda 2
JM - Giamaica 2
LV - Lettonia 2
MA - Marocco 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SM - San Marino 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BS - Bahamas 1
CG - Congo 1
DO - Repubblica Dominicana 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
JE - Jersey 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MQ - Martinica 1
NG - Nigeria 1
RE - Reunion 1
TM - Turkmenistan 1
WS - Samoa 1
Totale 6.641
Città #
Southend 881
Singapore 246
Ashburn 198
Chandler 168
Beijing 138
Hong Kong 117
Frankfurt am Main 85
Seattle 83
Santa Clara 81
Milan 79
San Jose 78
Jacksonville 73
Princeton 68
Council Bluffs 60
Dearborn 60
Dublin 60
Mountain View 51
Los Angeles 48
Ann Arbor 47
Ho Chi Minh City 46
Dallas 44
Hanoi 43
Wilmington 43
New York 41
Redmond 41
Toronto 38
Bengaluru 31
Des Moines 31
Serra 31
Boardman 30
Nanjing 28
Buffalo 25
Lauterbourg 25
Moscow 25
Woodbridge 25
Andover 24
Sakarya 24
Shanghai 24
Abidjan 23
Columbus 21
Guangzhou 21
Bogotá 19
Saint Petersburg 19
Jinan 17
The Dalles 17
Nanchang 16
Munich 15
Phoenix 15
Cangzhou 14
Fairfield 14
Somerville 14
Houston 13
Shenyang 13
Tianjin 13
Turin 13
Piscataway 12
Brussels 11
Da Nang 11
Hangzhou 11
Helsinki 11
San Diego 11
Tokyo 11
Jakarta 10
Jiaxing 10
Berlin 9
Kampala 9
Rome 9
Seoul 9
London 8
Zhengzhou 8
Cambridge 7
Changsha 7
Grafing 7
Hebei 7
Mumbai 7
San Antonio 7
Sydney 7
Chicago 6
Eitensheim 6
Fuzhou 6
Haiphong 6
Hefei 6
Montreal 6
Ottawa 6
Redwood City 6
Stockholm 6
São Paulo 6
Taipei 6
Belo Horizonte 5
Bitonto 5
Bologna 5
Istanbul 5
Johannesburg 5
Kent 5
Naples 5
Newark 5
Nuremberg 5
Orem 5
Scranton 5
Shenzhen 5
Totale 3.842
Nome #
Prevalence of psychiatric disorders during PEG – Interferon and Ribavirin therapy in patients with chronic hepatitis HCV-correlated 409
The dica endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists: An international study 294
The natural history of compensated cirrhosis due to hepatitis C virus : A 17-year cohort study of 214 patients 282
L'IMPATTO DEL POLIMORFISMO GENETICO IL 28B SUL TRATTAMENTO ANTIVIRALE CON INTERFERONE PEGHILATO E RIBAVIRINA IN PAZIENTI CON EPATITE CRONICA C GENOTIPO 4 281
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegykated interferon-α2A in chronic hepatitis C : an in vitro and in vivo study 279
Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C 263
Serum expression of lectin reactive alphafetoprotein, des-gamma-carboxy prothrombin, Golgi protein-73 antigen and antibody, for the diagnosis of hepatocellular carcinoma 254
The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy 252
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-alpha 2a in chronic hepatitis C : an in vitro and in vivo study 234
Genotype dependent pattern of peginterferon alfa-2b/ribavirin treatment failure in hepatiti sC virus infected patients with cirrhosis : a single center study of 471 naive patients 234
Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis C patients 233
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 233
Successful treatment of hepatocellular carcinoma (HCC) with transchateter arterial embolization (TAE) with microspheres (embosphere) 226
Predictors of psychopathological outcome during peg-interferon and ribavirin therapy in patients with chronic HCV-correlated hepatitis 225
Genotype dependent pattern of Peginterferon alfa-2B/Ribavirin treatment failure in hepatitis C virus infected patients with cirrhosis : a single centre study of 471 naïve patients 219
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotype 212
The diagnostic accuracy of fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with an SVR 211
The influence of liver fibrosis on the outcome of pegylated interferon and ribavirin anti-hac therapy : a sub-analysis of the mist study 210
Randomized Study of Peginterferon-alpha2a Plus Ribavirin vs Peginterferon-alpha2b Plus Ribavirin in Chronic Hepatitis C 209
Hepatitis C virus genotypes and patterns of peginterferon alfa-2b/ribavirin treatment failure in patients with cirrhosis : a single center study of 471 naïve patients 207
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study 207
Hyporesponsiveness to PegIFNα2B plus ribavirin in patients with hepatitis C-related advanced fibrosis 205
Successful treatment of hepatocellular carcinoma (hcc) with transchateter arterial embolization (tae) with microspheres (embosphere) 185
Interferoni pegilati nel trattamento dei pazienti con epatite cronica HCV : esperienze a confronti 184
Single-incision laparoscopic surgery (SILS) for the treatment of ileocolonic Crohn’s disease: a propensity score–matched analysis 178
Comparative trials of peginterferon α2a and peginterferon α2b for chronic hepatitis C 171
Lack of alanine aminotransferase normalization in patients with an anti-hcv virological response during pegylated interferon and ribavirin therapy : a sub-analysis of the mist study 168
Surgical treatment of colonic Crohn’s disease: a national snapshot study 167
Prospective evaluation of staging systems for hepatocellular carcinoma detected during surveillance of cirrhotic patients 158
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study 155
The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3 : Should we utilize more? 152
Totale 6.897
Categoria #
all - tutte 19.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.300


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022346 0 0 7 13 16 27 37 32 54 46 36 78
2022/2023537 60 78 56 56 45 114 9 15 65 7 28 4
2023/2024359 7 29 14 24 115 36 11 20 22 13 29 39
2024/2025845 39 84 7 111 82 29 22 58 48 95 79 191
2025/20261.718 217 93 158 103 156 99 224 85 117 141 187 138
2026/2027213 106 107 0 0 0 0 0 0 0 0 0 0
Totale 6.897